Evaluation of the clinical contribution in sepsis risk assessment with MR-proADM as an early biomarker of endothelial dysfunction: preliminary data from a cohort of critically ill patients tested by the LIAISON® BRAHMS MR-proADM™ Assay
Laura Grumiro, Simona Semprini, Emiliano Gamberini, Marina Terzitta et autres